Discovery of a Novel, Selective and Irreversible Inhibitor (Abivertinib) of Mutated EGFR and T790M-induced Resistance for the Treatment of NSCLC
本文档由 f061da46b0 分享于2020-05-13 19:09
Discovery of a Novel, Selective and Irreversible Inhibitor (Abivertinib) of Mutated EGFR and T790M-induced Resistance for the Treatment of NSCLC
下载文档
收藏
打印
分享:
君,已阅读到文档的结尾了呢~~